ArticleBMC urology2026
Impact of Tranexamic acid in reducing intra-operative blood loss during mono-polar TURP in geriatric population: a comparative study from Pakistan - a state highly prevalent of anemia.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn resource-limited countries, baseline anemia is highly prevalent among elderly patients. Elderly seeking surgical intervention for prostatic enlargement (PE) often find themselves in a clinical paradox: too unfit to endure surgery without risk yet too symptomatic to maintain an acceptable quality of life without intervention as surgery increases their vulnerability to the sequential surgical blood loss. Transurethral Resection of the Prostate (TURP) remains the gold-standard surgical treatment for PE. Intra-operative hemorrhage is its most common and significant complication. Tranexamic acid (TXA) is an antifibrinolytic agent proven to reduce bleeding in trauma. Studies exhibit improved intra-operative outcomes including decreased blood loss, reduced irrigation fluid and shorter operative times. METHODOLOGY: Conducted in Allied Hospital Faisalabad, 60 patients fulfilling inclusion criteria were enrolled. Two groups were made: Group-A received a single 1 g dose of TXA before induction of anesthesia while Group-B did not. Each group was further stratified by prostate weight: Subgroups A1/B1 (40-60 g) and A2/B2 (61-80 g). All patients underwent TURP and intra-operative blood loss was quantified using hemoglobin content in irrigation fluid with blood loss calculated via a standard equation. Resection time and resected tissue weight was recorded.
resultsMean prostate weight of 62 ± 10.7 g in Group-A patients and 62.5 ± 10.8 g in Group-B patients. Blood loss in TURP was 289 ± 76 ml in Group-A versus 357 ± 81 ml in Group-B. Blood loss per gram of resected tissue was 11.4 ± 1.3 ml/g in Group-A and 14 ± 2.8 ml/g in Group-B. Segregated group result shows that TXA significantly reduced blood loss and blood loss per gram specifically in the case of large prostate as compared to small ones.
conclusionIn our quasi-experimental trial, pre-operative single dose administration of TXA in patients undergoing monopolar TURP brings out satisfactory results. TXA significantly reduces the intra-operative blood loss and blood loss per gram along with reduction in volume of irrigating fluid and duration of surgery. The classified group results reveal that TXA acts approximately equal on large and small prostates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.